Dietary Hyperoxaluria
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days (NCT02547805) | Allena Pharmaceuticals | 2015-09-01 |
| Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones (NCT02503345) | Allena Pharmaceuticals | 2015-07-01 |
Track Dietary Hyperoxaluria automatically
Every clearance here is in the API, with alerts when new ones post.